Navigation Links
New Advances in Understanding of Parasite Risk Showcased at CVBD World Forum
Date:7/28/2010

ness of the symptomatology in clinical cases and the number of sub-clinically infected dogs entering the UK. According to Dr Shaw, "This increased prevalence raises the very real prospect of leishmaniosis becoming established in the UK if the sand fly vector appears in this country. Indeed, there is a worrying possibility that there is already transmission occurring in the UK, as a number of dogs in our study had no history of travel outside the UK at all." More information on Dr Shaw's study can be found at http://dx.doi.org/10.1016/j.vetpar.2009.03.025.

Further evidence of the risk posed by the movement of dogs within Europe was presented by Dr Torsten Naucke. Dr Naucke's study looked at more than 4,500 dogs imported into Germany, and found that nearly one in four (23.4%) were infected with babesiosis, and more than one in ten were infected with leishmaniosis (12.2%) and ehrlichiosis (10.1%). According to Dr Naucke, "Based on these findings the importation of dogs from endemic regions to Germany, as well as travelling with dogs to these regions carries a significant risk of acquiring an infection. We would recommend that pet owners seek the advice of their veterinarians prior to importing a dog from an endemic area or travel to such areas." For more information on Dr Naucke's finding, visit http://www.ncbi.nlm.nih.gov/pmc
'/>"/>

SOURCE Bayer HealthCare
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. ChemoCentryx Advances Second Orally Available CCR9 Antagonist CCX025 Into Clinical Development
2. New research field promises radical advances in optical technologies
3. Resverlogix Advances to Second Arm of Phase 1b/2a Clinical Trial
4. MDV Expands Team Pursuing Advances in Personalized Medicine
5. Advances in Detection Technology Drive the European Autoimmune Disease Diagnostics Market
6. New Colorectal Module From Simbionix Advances Laparoscopic Cancer Treatment
7. Alfred Mann Foundation for Biomedical Engineering Launches New Web Site Designed to Help University Researchers Bring Biomedical Advances to Market
8. New Report Provides Expert Analysis of Recent Advances and Setbacks in Parkinsons Disease Drug Development
9. MedImmune Advances Asthma Program With Start of Phase 2 Clinical Trial for Antibody Targeting IL-5 Receptor
10. NVIDIA CUDA Technology Dramatically Advances the Pace of Scientific Research
11. Recent Advances in Organic Chemistry Using Real-Time In Situ FTIR
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/20/2014)... ON , Oct. 20, 2014 /PRNewswire/ - BIOREM Inc. (TSXV: ... $1.7 million which brings Q3 orders to $5.8 million and provides ... control projects in North America and one ... continue to bid new projects at record levels," said Peter ... were higher at the end of Q3 than they have been ...
(Date:10/20/2014)... Oct. 20, 2014  GenVec, Inc. (NASDAQ: GNVC ... , Ph.D., from its board of directors effective on October ... 2003, and served as its chairman from June 2006 to ... Nominating and Corporate Governance and Audit Committees of the board.  ... a decade of dedicated service to GenVec, and its stockholders," ...
(Date:10/20/2014)... October 20, 2014 OncLive® ... Kimmel Cancer Center at Thomas Jefferson University has ... Through the Strategic Alliance Partnership program, the Sidney ... collaborate to raise awareness of the Center’s cutting-edge ... other projects. Clinicians and other health care professionals ...
(Date:10/20/2014)... OR (PRWEB) October 20, 2014 Local ... participate in an investigational study of donor stem cells ... in stem cell therapy and has performed clinical stem ... this study is to determine if a single injection ... affected joints can help reduce pain and inflammation in ...
Breaking Biology Technology:Zola P. Horovitz To Retire From GenVec Board 2Sidney Kimmel Cancer Center at Thomas Jefferson University Partners With OncLive 2Sidney Kimmel Cancer Center at Thomas Jefferson University Partners With OncLive 3Cascade Veterinary Referral Center Seeks Candidates for an Investigational Study of Stem Cells for Dogs with Arthritis 2
... Calif., Aug. 7 ISTA Pharmaceuticals,Inc. (Nasdaq: ISTA ), ... 2008. ISTA reported net revenue of $17.8 million for the,quarter ... quarter of 2007.,The net loss for the second quarter ended ... compared with a net loss of $8.7 million (or $0.32,per ...
... /PRNewswire-FirstCall/ - Chromos Molecular,Systems Inc. ("Chromos" or the ... arrangement agreement (the "Arrangement Agreement") dated,August 6, 2008 ... subsidiary of Chromos, and Modatech Systems Inc. ("Modatech"),pursuant ... agreed to effect a plan,of arrangement (the "Arrangement") ...
... in Health Sciences and Photonics, today announced that its analytical ... Food Safety Monitoring (BFSM) in a mobile laboratory supporting the ... for volatile organic compounds in beverages and pesticides in food ... ...
Cached Biology Technology:ISTA Pharmaceuticals Reports Second Quarter 2008 Financial Results 2ISTA Pharmaceuticals Reports Second Quarter 2008 Financial Results 3ISTA Pharmaceuticals Reports Second Quarter 2008 Financial Results 4ISTA Pharmaceuticals Reports Second Quarter 2008 Financial Results 5ISTA Pharmaceuticals Reports Second Quarter 2008 Financial Results 6ISTA Pharmaceuticals Reports Second Quarter 2008 Financial Results 7Chromos enters into an Arrangement Agreement 2Chromos enters into an Arrangement Agreement 3 PerkinElmer Expertise and Solutions Integral to Food Safety Monitoring for the Beijing Games : Methods, Applications Expertise and Instrumentation Deployed in Mobile Laboratory 2 PerkinElmer Expertise and Solutions Integral to Food Safety Monitoring for the Beijing Games : Methods, Applications Expertise and Instrumentation Deployed in Mobile Laboratory 3
(Date:10/16/2014)... constantly wages war on the human body. Battles ... stalemate. In pancreatic cancer, this stalemate—known as tumor ... aggressively malignant, a phenomena that is poorly understood. ... the laboratory of Salvatore Torquato, a Professor of ... conditions surrounding tumor dormancy and the switch to ...
(Date:10/16/2014)... and Washington land managers have a new synthesis of ... moist mixed-conifer (MMC) forests in the two states. ... in Eastern Oregon and Washington: A Synthesis of the ... a general technical report published by the U.S. Forest ... to a request from managers for a synthesis of ...
(Date:10/16/2014)... efficiently, they are anything but sustainable: environmental damage ... is becoming increasingly evident. Despite their disadvantages, however, ... regarded as the sole possibility of achieving higher ... Bernhard Schmid, an ecology professor at the University ... agriculture and forestry. After all, a new study ...
Breaking Biology News(10 mins):Modeling tumor dormancy 2New report synthesizes best available science on management of moist mixed-conifer forests 2Plant communities produce greater yield than monocultures 2Plant communities produce greater yield than monocultures 3
... using highly sophisticated equipment. Yet the Florida State University geochemist ... Tibet and camping in the foothills of the Himalayas ... that unique mix of skills, Wang was chosen to take ... prehistoric woolly rhino ever found. A paper describing the team,s ...
... WASHINGTON, D.C. The American Association for Cancer ... Science of Cancer Health Disparities from Sept. 18-21, 2011, ... This conference will bring together scientists, survivors, ... cancer genetics, epidemiology and treatment methods to better meet ...
... pheromone-baited bucket traps, canines to sniff out breeding sites, ... the coconut rhinoceros beetle (CRB) on Guam with the ... tactics. USDA has given Guam an infusion of cash ... population on island. Aubrey Moore, entomologist and researcher with ...
Cached Biology News:A wild and woolly discovery: FSU scientist's Tibetan expedition ends with prehistoric find 2A wild and woolly discovery: FSU scientist's Tibetan expedition ends with prehistoric find 3AACR to host conference on the science of cancer health disparities 2
Mouse monoclonal antibody to ACP2 - acid phosphatase 2, lysosomal...
... platform, 220 V, is used for agitation and ... cultures, staining and destaining of gels and blots, ... control (8-40 rpm) and can handle a maximum ... features two 29 x 21 cm platforms covered ...
... 2,2′-Azino- bis (3-ethylbenzthiazoline-6-sulfonic Acid) Clear ... of ABTS and H 2 O 2 ... stabilizers. Peroxidase substrate that is soluble, safe, convenient ... ™ develops intense blue-green color that can ...
...
Biology Products: